Prof. Dr. Med. Philip Tarr
Phyisician-Scientist (Internal Medicine, Infectious Diseases)
Universität Basel
Basel, Switzerland
About me
Prof. Philip E. Tarr, MD, graduated from University of Zurich Switzerland Medical School in 1994. He completed medical internship at Beth Israel Deaconess Medical Center/ Harvard Medical School (Boston, MA), obtained Infectious Diseases Fellowship training at the National Institutes of Allergy and Infectious Diseases (NIH, Bethesday, MD), and Molecular Biology training at Albert Einstein College of Medicine in New York. He was junior staff member in infectious diseases at Lausanne University Hospital (CHUV) in Switzerland (2002-2007), before taking on a job as chief of infectious diseases in the University Dept. of Medicine at Kantonsspital Baselland near Basel/Switzerland in 2007, and chief of internal medicine in 2016.
Philip’s research into the metabolic and aging-associated complications in HIV has been supported by the Swiss National Science Foundation and the Swiss HIV Cohort Study since 2010. Since 2011, Philip has been the chairman of the Swiss HIV Cohort Study’s Core Project Metabolism and Aging. From 2017 to 2022 he directed the Swiss National Research Program NFP74 on vaccine hesitancy. In 2017, he was responsible author of a handbook commissioned by the Swiss Federal Office of Public Health on vaccines and outbreak prevention and management in Swiss Federal immigrant centers.
My organisation
Skills
- Research
- Immunology
- patient-centered medicine
Interests
- infectious diseases
- Vaccine hesitancy
- Metabolism and Aging
Speaker sessions (1)
Thursday, 9 November 2023
11:00 - 12:00
Transition from Fighting disease to Health promotion (external speakers)
- 11.00 – 11.20: The transition from fighting disease to health promotion in healthcare (Prof. Dr. Sandra van Hogen-Koster, Positive Health, UAS Saxion)
- 11.20 – 11.40: Infections prevention and treatment (human medicine) (Prof. Philip Tarr, Univ. of Basel)
- 11.40 – 12.00: Disease prevention and veterinary treatment in organic production (Dr. Laurence Bonafos, Policy Coordinator, DG AGRI, European Commission)
There is a need for a transition in medicine and prevention from a Fighting disease to a Health promotion approach; in general and also for prevention and treatment of infections; this may include the contributions of TCIH.